Adjuvant immune checkpoint blockade revisited.

van Waalwijk van Doorn-Khosrovani, Sahar Barjesteh; Huisman, Atse; Roy, Anke Pisters-van; Koole, Simone; Timmers, Lonneke; Blank, Christian; Gelderblom, Hans

van Waalwijk van Doorn-Khosrovani, Sahar Barjesteh; Huisman, Atse; Roy, Anke Pisters-van; Koole, Simone; Timmers, Lonneke; Blank, Christian; Gelderblom, Hans.

Afiliação

van Waalwijk van Doorn-Khosrovani SB; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, Netherlands; Medical Department, CZ Health Insurance, Tilburg, Netherlands. Electronic address: sahar.van.waalwijk@cz.nl.
Huisman A; Department of Health Policy, Zorgverzekeraars Nederland, Zeist, Netherlands.
Roy AP; Medical Department, CZ Health Insurance, Tilburg, Netherlands.
Koole S; Medical Department, ONVZ Health Insurance, Houten, Netherlands.
Timmers L; Scientific Advisory Board, National Health Care Institute (Zorginstituut Nederland), Diemen, Netherlands.
Blank C; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, Netherlands; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.
Gelderblom H; Department of Medical Oncology, Leiden University Medical Centre, Albinusdreef 2, 2333 ZA, Leiden, Netherlands.

Lancet Oncol ; 24(7): 717-719, 2023 07.

Article em En | MEDLINE | ID: mdl-37414008

Assuntos

Anticorpos Monoclonais; Inibidores de Checkpoint Imunológico; Humanos; Imunoterapia/efeitos adversos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Anticorpos Monoclonais Limite: Humans Idioma: En Revista: Lancet Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google